Revenue: not reported (N/A) in QQ4 2024; Gross Profit: N/A; Operating Income: -$176,441 (- QoQ -131.01%; -2,533.45% YoY); Net Income: $907,068 (+13,638.33% YoY; -18.54% QoQ); EBITDA: -$176,441; EPS (basic/diluted): $0.210 / $0.0576; Weighted Avg Shares (outstanding): 4,249,090; Diluted Shares: 15,749,090.
Cash Flow and liquidity: Net cash from operating activities -$375,235; Free cash flow -$375,235; Net cash used in investing activities -$315,000; Net cash used/provided by financing activities $147,629; Net change in cash $87,394; Cash at end of period $910,193; Cash at beginning $822,799.
Balance Sheet: Total assets $119,800,388; Long-term investments $118,601,873; Cash and cash equivalents $822,799; Total current assets $1,198,515; Total current liabilities $722,230; Total liabilities $722,230; Stockholdersโ equity $119,078,158; Net debt (-) $822,799.
Valuation and efficiency metrics: Price-to-earnings (trailing) 11.86; Price-to-book 0 (no apparent traditional book value per share alignment); Price-to-Earnings Growth (PEG) 0.0602; Operating cash flow per share -$0.0883; Free cash flow per share -$0.0883; Free cash flow-to-operating cash flow ratio effectively 1.00 (per reported metric).